US Patent Issued to Boston Medical Center, The Trustees of the University of Pennsylvania on July 29 for "Nucleoside modified mRNA and uses thereof" (Massachusetts, Pennsylvania Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,666, issued on July 29, was assigned to Boston Medical Center Corp. (Boston) and The Trustees of the University of Pennsylvania (Philadelphia).

"Nucleoside modified mRNA and uses thereof" was invented by Valerie Gouon-Evans (Newton, Mass.), Drew Weissman (Philadelphia) and Norbert Pardi (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application discloses compositions and methods for use of nucleoside modified mRNA that encode for at least one liver regenerative factor. The present invention also relates to compositions and methods for use of nucleoside modified mRNA complexed to nanoparticles. The disclosed compositions and...